Your browser doesn't support javascript.
loading
Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre study.
Mallucci, Giulia; Annovazzi, P; Miante, S; Torri-Clerici, V; Matta, M; La Gioia, S; Cavarretta, R; Mantero, V; Costantini, G; D'Ambrosio, V; Zaffaroni, M; Ghezzi, A; Perini, P; Rossi, S; Bertolotto, A; Rottoli, M R; Rovaris, M; Balgera, R; Cavalla, P; Montomoli, C; Bergamaschi, R.
Afiliación
  • Mallucci G; Inter-department Multiple Sclerosis Research Centre, IRCCS Mondino Mondino, Pavia, Italy. giulia.mallucci@mondino.it.
  • Annovazzi P; Multiple Sclerosis Study Centre, ASST Valle Olona, Gallarate, VA, Italy.
  • Miante S; Department of Neurosciences, The Multiple Sclerosis Centre, University Hospital of Padova, Padua, Italy.
  • Torri-Clerici V; Department of Neuroimmunology and Neuromuscular Diseases, Neurological Institute C, Besta IRCCS Foundation, Milan, Italy.
  • Matta M; Regional Multiple Sclerosis Centre, San Luigi Gonzaga Hospital, Orbassano, TO, Italy.
  • La Gioia S; SS Malattie Autoimmuni USC Neurologia, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
  • Cavarretta R; Multiple Sclerosis Center, IRRCS Santa Maria Nascente, Fondazione Don Carlo Gnocchi, Milan, Italy.
  • Mantero V; Neurological Department, A. Manzoni Hospital, Lecco, Italy.
  • Costantini G; Department of Neuroscience, University of Torino, Turin, Italy.
  • D'Ambrosio V; Inter-department Multiple Sclerosis Research Centre, IRCCS Mondino Mondino, Pavia, Italy.
  • Zaffaroni M; Multiple Sclerosis Study Centre, ASST Valle Olona, Gallarate, VA, Italy.
  • Ghezzi A; Multiple Sclerosis Study Centre, ASST Valle Olona, Gallarate, VA, Italy.
  • Perini P; Department of Neurosciences, The Multiple Sclerosis Centre, University Hospital of Padova, Padua, Italy.
  • Rossi S; Department of Neuroimmunology and Neuromuscular Diseases, Neurological Institute C, Besta IRCCS Foundation, Milan, Italy.
  • Bertolotto A; Regional Multiple Sclerosis Centre, San Luigi Gonzaga Hospital, Orbassano, TO, Italy.
  • Rottoli MR; SS Malattie Autoimmuni USC Neurologia, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
  • Rovaris M; Multiple Sclerosis Center, IRRCS Santa Maria Nascente, Fondazione Don Carlo Gnocchi, Milan, Italy.
  • Balgera R; Neurological Department, A. Manzoni Hospital, Lecco, Italy.
  • Cavalla P; Department of Neuroscience, University of Torino, Turin, Italy.
  • Montomoli C; Unit of Biostatistics and Clinical Epidemiology, Department of Public Health, University of Pavia, Pavia, Italy.
  • Bergamaschi R; Inter-department Multiple Sclerosis Research Centre, IRCCS Mondino Mondino, Pavia, Italy.
J Neurol ; 265(8): 1850-1859, 2018 Aug.
Article en En | MEDLINE | ID: mdl-29948245
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dimetilfumarato / Inmunosupresores Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Neurol Año: 2018 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dimetilfumarato / Inmunosupresores Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Neurol Año: 2018 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Alemania